Perrigo (PRGO) Misses Q4 EPS by 3c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Perrigo Company plc Reports Fourth Quarter And Full-Year 2018 Financial Results
February 27, 2019 4:01 PM ESTDUBLIN, Feb. 27, 2019 /PRNewswire/ --
Full-year 2018 GAAP ("Reported") net sales of $4.7 billion, reflecting a 4% decline versus a year ago; Fourth quarter 2018 reported net sales of $1.2 billion, a 7% decline versus the prior year. Full-year 2018 Worldwide Consumer businesses reported net sales of $3.9 billion, relatively flat year-over-year; Fourth quarter Worldwide Consumer businesses reported net sales of $973 million, down 4% year-over-year. Full-year 2018 Worldwide Consumer businesses net sales grew approximately 1% on an organic constant currency basis, excluding the year-over-year negative impact from the animal health business. Prescription Pharmaceuticals ("RX") fourth-quarter net sales of $222 million,... More